WTO

“CBL” articles

Why AI-Enabled Antibody Engineering Is Becoming a Competitive Advantage in Biologics

Antibody engineering, once defined by trial-and-error approaches and lengthy optimization cycles, is being reshaped by computational platforms capable of learni
28 Jan 2026
Read more
CBL

Naturally Occurring vs. Phenotypic: Which Ex Vivo Skin Model Fits Your Research?

Keywords: Ex Vivo Skin Models, Naturally Occurring Skin Disease Model, Phenotypic Skin Disease Model, Fibroblast Activation Assay, Psoriasis Model, 3D Biology
28 Jan 2026
Read more
CBL

2026 ADC Landscape: What Emerging Payloads Reveal About the Future of Targeted Therapies

Although more than a decade has passed since the approval of the first ADC, payload development remains one of the fastest-moving components of the field. With
28 Jan 2026
Read more
CBL

Mastering Immune Regulation: The Pivotal Roles of FOXP3, GITR, KLRG1, and FOXP1 in T Cell Biology

Central to this balance are regulatory T cells (Tregs) and effector T cells, whose functions are governed by specific molecular markers and transcription factor
28 Jan 2026
Read more
CBL

Advertisement